When.com Web Search

  1. Ad

    related to: maker of zocor and fosamax free

Search results

  1. Results From The WOW.Com Content Network
  2. Teva Pharmaceuticals - Wikipedia

    en.wikipedia.org/wiki/Teva_Pharmaceuticals

    In June 2006, Teva received from the FDA a 180-day exclusivity period to sell simvastatin (Zocor) in the U.S. as a generic drug in all strengths except 80 mg. Teva presently [when?] competes with the maker of brand-name Zocor, Merck & Co.; Ranbaxy Laboratories, which has 180-day exclusivity for the 80 mg strength; and Dr. Reddy's Laboratories ...

  3. Simvastatin - Wikipedia

    en.wikipedia.org/wiki/Simvastatin

    Simvastatin, sold under the brand name Zocor among others, is a statin, a type of lipid-lowering medication. [4] It is used along with exercise, diet, and weight loss to decrease elevated lipid levels. [4] It is also used to decrease the risk of heart problems in those at high risk. [4] It is taken by mouth. [4]

  4. Alendronic acid/colecalciferol - Wikipedia

    en.wikipedia.org/wiki/Alendronic_acid/colecalciferol

    Alendronic acid/colecalciferol, sold under the brand name Fosamax Plus D among others, is a medication for the treatment of osteoporosis in men or in postmenopausal women. [ 3 ] [ 2 ] [ 4 ] [ 6 ] Alendronic acid/colecalciferol was approved for use in the United States and in the European Union in 2005.

  5. FDA Approves Powerful New Cholesterol Drug

    www.aol.com/news/2013-05-03-fda-approves...

    For premium support please call: 800-290-4726 more ways to reach us

  6. Top Treatments for High Cholesterol

    www.aol.com/2013/06/17/top-treatments-for-high...

    For premium support please call: 800-290-4726 more ways to reach us

  7. Approved Drug + Approved Drug = Rejection? - AOL

    www.aol.com/news/2012-03-05-approved-drug...

    For premium support please call: 800-290-4726 more ways to reach us

  8. Ezetimibe/simvastatin - Wikipedia

    en.wikipedia.org/wiki/Ezetimibe/simvastatin

    With median follow-up of 6 years, simvastatin+ezetimibe was found to reduce the primary outcome of CV mortality, major CV event, or nonfatal stroke (34.7% vs. 32.7%; P=0.016; NNT 50 per 7 years or NNT 350 per 1 year ). There was no reduction in all-cause or CV mortality with simvastatin+ezetimibe, though there was a reduction in MI and stroke. [6]

  9. Pharmaceutical industry - Wikipedia

    en.wikipedia.org/wiki/Pharmaceutical_industry

    Researchers tested simvastatin, later sold by Merck as Zocor, on 4,444 patients with high cholesterol and heart disease. After five years, the study concluded the patients saw a 35% reduction in their cholesterol, and their chances of dying of a heart attack were reduced by 42%. [74] In 1995, Zocor and Mevacor both made Merck over US$1 billion.